We provide you with 20 years of free, institutional-grade data for BCLI stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of BCLI. Explore the full financial landscape of BCLI stock.
| Reported Date | CIK | Ticker | Type |
|---|
Brainstorm Cell Therapeutics Inc(NASDAQ:BCLI) 
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company holds rights to develop and commercialize its NurOwn technology that utilizes cell culture method...
Website: http://www.brainstorm-cell.com
Founded: 2000
Full Time Employees: 44
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about BCLI stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.